Inhibitory Receptors in Eosinophils of Atopic Subjects

Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01489293

Enrollment

Registered

2011-12-09

Start date

2012-05-01

Completion date

2013-12-31

Last updated

2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Asthma, Atopic Dermatitis, Atopy, Food Allergy

Brief summary

The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* age 20-60 years * a physician-diagnosed atopic disease

Exclusion criteria

* atopic disease not active * steroid treatment * active non-atopic inflammatory disease, including infections * pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Expression of surface molecules on eosinophils as assessed by flow cytometry	December 2013	Blood samples from donors will be stained and evaluated by flow cytomtery

Countries

Israel

Outcome results